Indication
Testicular Cancer
12 clinical trials
13 products
8 drugs
Clinical trial
A Phase II Clinical Study to Evaluate the Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid TumorStatus: Completed
Product
Tc 99m EC20Product
Systemic TreatmentClinical trial
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)Status: Recruiting, Estimated PCD: 2029-10-01
Clinical trial
PET Biodistribution Study of 68Ga-FAPI-46 in Patients With Different Malignancies: An Exploratory Biodistribution Study With Histopathology ValidationStatus: Recruiting, Estimated PCD: 2024-07-01
Product
Gallium Ga 68 FAPi-46Clinical trial
Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular CancerStatus: Active (not recruiting), Estimated PCD: 2024-07-05
Clinical trial
Phase 2 Study Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ CellStatus: Terminated, Estimated PCD: 2022-12-31
Drug
cabazitaxelProduct
AxuminClinical trial
An Early Phase 1 Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Patients With Hepatic or Renal Dysfunction and Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2017-11-10
Product
CarboplatinDrug
TiragolumabProduct
VeliparibClinical trial
Phase I Trial to Evaluate Safety and Preliminary Efficacy of CLDN6/GPC3/Mesothelin/AXL-CAR-NK in Patients With CLDN6/GPC3/Mesothelin/AXL-positive Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Short-term Testosterone Replacement in Testicular Cancer Survivors to Treat Overweight and Improve Cardiometabolic Risk: A Pilot StudyStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Product
AndrogelDrug
VarlilumabClinical trial
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma. A Multicenter, Open Label Phase II Trial With Two CohortsStatus: Active (not recruiting), Estimated PCD: 2026-12-31
Drug
AN0025Drug
CisplatinProduct
EtoposideClinical trial
WEST-KOaST Study: WES (Whole Exome Sequencing) Analysis of Testicular Cancer Patientsand Their First-degree Family MembersStatus: Not yet recruiting, Estimated PCD: 2025-09-21
Clinical trial
A Phase III Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer Receiving 5-day Cisplatin Combination ChemotherapyStatus: Recruiting, Estimated PCD: 2023-12-31
Product
OlanzapineClinical trial
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell TumorsStatus: Completed, Estimated PCD: 2024-01-11
Drug
GemcitabineDrug
DocetaxelDrug
MelphalanProduct
MesnaProduct
Ifosfamide